メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

In vivo and in vitro imaging of I2 imidazoline receptors in the monkey brain

  • Kazunori Kawamura
  • , Jun Maeda
  • , Akiko Hatori
  • , Takashi Okauchi
  • , Yuji Nagai
  • , Makoto Higuchi
  • , Tetsuya Suhara
  • , Toshimitsu Fukumura
  • , Ming Rong Zhang

研究成果: ジャーナルへの寄稿学術論文査読

抄録

I2 imidazoline receptors (I2Rs) are associated with depression, Alzheimer's disease, and Huntington's disease. However, in vivo imaging of I2Rs in the monkey brain has not been reported until now. We performed in vitro and in vivo imaging of (I2Rs) in the monkey brain using 11C-labeled 2-(3-fluoro-4-tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD) which has high and selective affinity of I2Rs. In an auto-radiography (ARG) study, the distribution pattern of [11C]FTIMD in the monkey brain was similar to that of [3H]idazoxan binging to I2Rs in the human brain, which was previously described. The specific binding of [11C]FTIMD accounted for >97% of total binding in brain regions existing I2Rs. In positron emission tomography (PET) studies, the radioactivity was accumulated in brain regions existing I2Rs ligand BU224, the accumulated radioactivity was decreased to approximately 66%-75% of the baseline measurement at 15-45 min after injection of [11C]FTIMD. These results suggest that [11C]FTIMD shows the specific-binging to I2Rs in the monkey brain as depicted by PET and ARG. We performed the first in vivo imaging of I2Rs using [11C]FTIMD in the monkey brain. Synapse, 2011. © 2010 Wiley-Liss, Inc.

本文言語英語
ページ(範囲)452-455
ページ数4
ジャーナルSynapse
65
5
DOI
出版ステータス出版済み - 05-2011
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 細胞および分子神経科学

フィンガープリント

「In vivo and in vitro imaging of I2 imidazoline receptors in the monkey brain」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル